Literature DB >> 17665459

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis.

Stuart M Levine1, Nina Raben, Dan Xie, Frederic B Askin, Rubin Tuder, Marissa Mullins, Antony Rosen, Livia A Casciola-Rosen.   

Abstract

OBJECTIVE: We previously proposed that novel expression and/or conformation of autoantigens in the target tissue may play a role in generating phenotype-specific immune responses. The strong association of autoantibodies to histidyl-transfer RNA synthetase (HisRS, Jo-1) with interstitial lung disease in patients with myositis led us to study HisRS expression and conformation in the lung.
METHODS: Normal human tissue specimens were probed with a novel anti-HisRS antibody recognizing its granzyme B-cleavable conformation by immunoblotting and immunohistochemistry. The HisRS granzyme B site was mapped using site-directed mutagenesis, and its relationship to the antibody recognition domain was evaluated in tandem immunoprecipitation/granzyme B cleavage studies.
RESULTS: The HisRS alpha-helical coiled-coil N-terminal domain recognized by autoantibodies is bounded by a granzyme B cleavage site. In immunoprecipitation studies with patient sera, HisRS was found to exist in 2 conformations, defined by sensitivity to cleavage by granzyme B and modification by autoantibody binding. Despite similar global expression of HisRS in different tissue, expression of its granzyme B-cleavable form was enriched in the lung and localized to the alveolar epithelium.
CONCLUSION: A proteolytically sensitive conformation of HisRS exists in the lung, the target tissue associated with this autoantibody response. We thus propose that autoimmunity to HisRS is initiated and propagated in the lung.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665459     DOI: 10.1002/art.22790

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  36 in total

Review 1.  Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

2.  Occupational exposure in patients with the antisynthetase syndrome.

Authors:  Ane Labirua-Iturburu; Albert Selva-O'Callaghan; Jan-Paul Zock; Ramon Orriols; Xavier Martínez-Gómez; Miquel Vilardell-Tarrés
Journal:  Clin Rheumatol       Date:  2014-01-03       Impact factor: 2.980

3.  Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

Authors:  Nathaniel M Green; Krishna-Sulayman Moody; Michelle Debatis; Ann Marshak-Rothstein
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

Review 4.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

5.  Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.

Authors:  John C Hall; Livia Casciola-Rosen; Alan E Berger; Efstathia K Kapsogeorgou; Chris Cheadle; Athanasios G Tzioufas; Alan N Baer; Antony Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

6.  Environmental exposure in inflammatory myositis.

Authors:  A N Costa; L Kawano-Dourado; S K Shinjo; C R R Carvalho; R A Kairalla
Journal:  Clin Rheumatol       Date:  2014-03-21       Impact factor: 2.980

Review 7.  Diagnosis and classification of idiopathic inflammatory myopathies.

Authors:  I E Lundberg; F W Miller; A Tjärnlund; M Bottai
Journal:  J Intern Med       Date:  2016-07       Impact factor: 8.989

8.  Autoantibodies and their significance in myositis.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 9.  Granzyme B cleavage of autoantigens in autoimmunity.

Authors:  E Darrah; A Rosen
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

Review 10.  A critical role for immature muscle precursors in myositis.

Authors:  Anne Tournadre; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2013-03-12       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.